Cubist Systematic Strategies’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Cubist Systematic Strategies’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-13,885	Closed	-$749K	–	2229
2017 Q4	$749K	Sell	13,885 -11,869	-46%	-$649K	0.04%	647
2017 Q3	$1.47M	Buy	25,754 +20,724	+412%	+$1.21M	0.08%	269
2017 Q2	$303K	Buy	5,030 +872	+21%	+$49.7K	0.02%	1029
2017 Q1	$226K	Buy	+4,158	New	+$205K	0.02%	1101

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Cubist Systematic Strategies's BIVV Position: Q1 2018 in Review

Cubist Systematic Strategies sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 13,885 shares — an estimated $749K sold.

Cubist Systematic Strategies first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $1.47M in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Cubist Systematic Strategies reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Cubist Systematic Strategies sold 13,885 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $749K.
Cubist Systematic Strategies first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Cubist Systematic Strategies's Bioverativ Inc. Common Stock position peaked at $1.47M in Q3 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Cubist Systematic Strategies's 13F filing for Q1 2018, filed 15 May 2018.